Risk factor
Very poor trading liquidity
Profitability factor
Slightly undervalued vs peers
About
Smruthi Organics Ltd. primarily focuses on the production and commercialization of bulk pharmaceutical ingredients and their chemical intermediates. The company's product range includes a variety of compounds such as amlodipine besilate, amisulpride, carbidopa, ciprofloxacin, diloxanide furoate, fenofibrate, metformin hydrochloride, norfloxacin, pefloxacin, telmisartan, amlodipine base, and phthaloyl amlodipine. This enterprise was established on July 11, 1989, by Purushotham Mallayya Eaga and is based in Solapur, India.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'che